A recent study demonstrated the lack of beta-amyloid (Aβ) plaque formation and accumulation of the amyloid precursor protein (APP) in a triple transgenic mouse model of Alzheimer’s disease (3xTg-AD) following overexpression of the anti-apoptotic protein, Bcl-2 (Rohn et al., J. Neurosci. 28: 3051-9, 2008). The supposition from that study was the accumulation of APP resulted from a decrease in caspase-mediated processing of APP. To determine a direct role for the caspase-cleavage of APP in 3xTg-AD mice, we designed a site-directed caspasecleavage antibody to APP and demonstrated it is a specific marker for caspase-cleaved APP. Application of this antibody revealed neuronal staining in the hippocampus and subiculum of 3xTg-AD mice. These results were confirmed utilizing a similar site-directed antibody to caspase-cleaved APP (APPneo). The caspase cleavage of APP as well as the formation of extracellular Aβ plaques was prevented in 3xTg-AD animals overexpressing Bcl-2. These results provide further support that caspases play a proximal role in promoting the pathology associated with AD.
This document was originally published by e-Century Publishing in International Journal of Physiology, Pathophysiology and Pharmacology. Copyright restrictions may apply. URL: http://www.ijppp.org/files/IJPPP901001.pdf
Kumasaka, Debra K.; Galvan, Veronica; Head, Elizabeth; and Rohn, Troy T.. (2009). "Caspase Cleavage of the Amyloid Precursor Protein is Prevented After Overexpression of Bcl-2 in a Triple Transgenic Mouse Model of Alzheimer’s Disease". International Journal of Physiology, Pathophysiology and Pharmacology, 48-56.